Arthroscopic Osteochondral Transplantation

Published on 11/03/2015 by admin

Filed under Orthopaedics

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1411 times

CHAPTER 15 Arthroscopic Osteochondral Transplantation

Successful treatment of articular cartilage lesions is a complex clinical issue. The mechanical demands placed on articular cartilage in the knee °require it to withstand shear and compressive loads. Additionally, the patients themselves are often demanding, wishing to continue an already active lifestyle. This is further complicated by the limited healing potential of articular cartilage. The clinical outcome of a focal cartilage defect is highly dependent on the size, depth, pattern, and location of the injury. Multiple grading schemes have been described in an effort to quantify this, and hopefully will steer effective clinical treatment. However, no general consensus exists regarding the treatment of these lesions, and controversy continues to surround this topic.

Techniques for marrow stimulation, such as abrasion arthroplasty, drilling, and microfracture, produce fibrocartilage rather than native hyaline cartilage. Good short- and midterm results have been reported by various authors. However, inconsistent long-term results have perpetuated the interest in finding alternative methods for treating full-thickness chondral lesions. These include autologous chondrocyte implantation, autologous osteochondral transplantation, fresh osteochondral allografting, and bulk allografting, as well as a whole host of synthetics, scaffolds and first-, second-, and third-generation cell-based technologies.14 This chapter will focus on the COR system (DePuy Mitek; Raynham, Mass) for arthroscopic osteochondral transplantation.

The idea for the COR technique has its origins in an observation from anterior cruciate ligament (ACL) reconstruction that routine notchplasty is not associated with postoperative clinical sequelae. Because of this, the “notched” area (marginal cartilage in the lateral trochlear groove) of the knee can be used elsewhere, with minimal or no donor site morbidity. The design rationale for this technique is simple:

ANATOMY

Hyaline cartilage is has no nerve fibers and is avascular, deriving nutrition from its surrounding synovial fluid. Additionally, hyaline cartilage is composed mostly of matrix, with a relative paucity of live, active cellular material. Because of this, full-thickness articular cartilage defects have limited healing potential. When native healing of such defects occurs, fibrocartilage is formed in the defect. This is the goal of marrow-stimulating techniques, in which osseous bleeding at the defect initiates a cascade of fibrous scar healing. However, fibrocartilage is not as mechanically sound as hyaline cartilage under compressive or shear loads.

In adults, hyaline cartilage normally has a thickness of roughly 8 to 9 mm. As a person ages, the articular cartilage thins. The presence of pathology can accelerate this eroding process. To produce symptoms, articular cartilage must be thinned by more than 75% before subchondral nerve fibers can detect the change in contact surface pressure. However, overall size of the lesion also plays a role in this. A small chondral defect will not produce symptoms because the stress is distributed to the surrounding joint surface. Only when the cartilage defect becomes large enough, and thin enough will the patient become symptomatic.

To illustrate this point, Jason and Koh5 have examined the contact pressures across an articular surface with respect to a focal defect and a grafted defect. Various graft height mismatches were modeled (Fig. 15-1), with the results shown in Table 15-1. Not surprisingly, plugs that were flush to their articular surfaces most closely resembled the contact pressure of the normal intact articular surface. However, plugs countersunk by 0.5 to 1.0 mm also closely mimicked the native pressures. Thus, filling a defect to a near-congruent articular surface can reproduce native articular-surfaced pressures. This is the foundation of autogenous osteochondral transplantation.

TABLE 15-1 Effect of Graft Height Mismatch on Contact Pressures

Condition of Intra-articular Joint Surface Contact Surface Pressure (kg/cm2)
Normal intact surface 9.77
Open 4.5-mm hole 12.00
Plug flush to the surface 9.08
Plug countersunk 0.5 mm to surface 10.54
Plug countersunk 1.0 mm to surface 10.84
Plug 0.5 mm proud to the surface 14.46
Plug 1.0 mm proud to the surface 15.30

Autogenous osteochondral transplantation, or mosaicplasty, is a technique in which multiple smaller grafts are harvested from a less weight-bearing portion of the knee and transplanted to the clinically relevant defect. The use of several small grafts has several advantages: (1) it allows the surgeon to reconstruct the natural anatomic contour lost by the defect; (2) it provides some hyaline surface structure to the reconstruction; (3) it limits fibrous cartilage growth to the gaps between the grafts and defect border; (4) it reduces donor site morbidity; (5) it is relatively inexpensive; and (6) the entire reconstruction can be done in a single surgery.

Because small chondral defects will not produce symptoms, the goal of osteochondral transplantation is to decrease the size of large defects functionally to become less clinically significant.

TREATMENT

Treatment should be tailored to various presenting factors. These include location and size of the lesion, age and weight of the patient, occupation, and type of sports involvement.

Indications and Contraindications

The COR system permits the arthroscopic harvesting of precisely sized articular cartilage–cancellous bone autografts from a suitable donor site, followed by the transplantation of these autografts to a precisely drilled defect site. The system can be used for open procedures if access to the defect or donor site is difficult. Indications for the procedure are single, full-thickness lesions at least 10 mm in diameter but not more than 35 mm in length or width. The depth of subchondral bone loss should not exceed 6 mm. Similar systems, although with some differences in design, are offered by the OATS system (Arthrex; Naples, Fla) and mosaicplasty (Smith and Nephew Endoscopy; Andover, Mass).

Indications for this procedure are as follows:

Contraindications include a history of degenerative joint disease or joint infection, intra-articular fracture, a diseased donor site, and multicompartment involvement. Additional physical contraindications relate to poor supporting bone at the recipient site, including a very large defect (more than 3 cm diameter), a deep defect (more than 6 mm deep), and extremely osteopenic subchondral bone stock. ACL disruption is not a contraindication, but concurrent ACL reconstruction is recommended in that case. Meniscal tears or prior surgeries on the lesion are not contraindications. No other area of significant chondral fibrillation or damage should be present. This technique is best performed on the femoral condyles and not on the tibial plateau.

Arthroscopic Technique

Harvesting COR Grafts

Insert the harvester (T-handled instrument) into the disposable cutter, screwing them together (Fig. 15-2). Advance the plunger through the lumen of the harvester, where it acts like an obturator to minimize soft tissue capture when passing the instruments into the joint. Once the assembly is properly positioned within the joint, replace the plunger with the anvil to minimize loss of fluid while harvesting grafts.

Position the cutter-harvester assembly on the non–weight-bearing donor site selected to provide the graft (Fig. 15-3). Ensure that the end of the cutter is almost perpendicular to the surface prior to taking the donor graft. In the knee, the superior and lateral aspects of the intercondylar notch may provide easiest arthroscopic access.

With a mallet, tap the anvil portion of this assembly into the bone 8 mm until it is fully seated at the cutter’s depth stop. Rotate the T handle of the harvester clockwise a minimum of two complete revolutions. The cutter tooth undercuts the distal bone, scoring it to ensure precise harvesting of a donor plug. Supportive pressure must be maintained on the T handle during rotation to ensure control of plug depth. Remove the cartilage graft by gently twisting the T handle while withdrawing it from the joint.

Unscrew the harvester from the cutter. The bone graft will remain protected within the harvester tube until it is ready for transplantation into the defect site. If additional bone grafts are required to repair the defect, the cutter can be assembled onto another harvester and the process repeated until the appropriate number of grafts has been taken.

Cartilage Graft Implantation

Screw the delivery guide onto the harvester, which contains the first graft to be delivered. Place the tip of the plunger through the spacer ring into the proximal end of the harvester. Gently tap the plunger, advancing the bone graft beyond the tip of the deliver guide, as limited by the spacer ring. This 1- to 2-mm lead of bone assists in aligning the graft with the drill hole as it is inserted into the recipient site.

Position the graft over the drill hole. Withdraw the plunger from the harvester, removing the spacer ring. Gently reinsert the plunger, carefully pressing the plug to fit in the undersized drill hole, flush with the surrounding bone (Fig. 15-4). Excess prominences may be trimmed with a basinet. Avoid impacting the graft to round off the corners, because this will mushroom the graft and damage the graft’s integrity.

If the defect is deep or the decision is made to place a solitary graft (or grafts) away from the margin of the defect, the delivery guide may be partially unscrewed to reduce the insertion depth of the graft. This allows for a supportive press fit between the sides of the plug and drill hole while maintaining an elevated face on the cartilage graft.

PEARLS& PITFALLS

PEARLS

Recipient Site

OUTCOMES

Patient selection is paramount to success of this technique. Because of the relatively narrow indications listed above, the senior author’s experience (JCYC) includes only 40 cases from 1996 to May 2009. This includes 23 women and 17 men, ranging in age from 20 to 75 years (mean, 50.5 years). The defects ranged from 1.5 to 3 cm in diameter, with the exception of one case.

Patient follow-up results have been monitored. In 1999, 3-year results showed 86% with good to excellent results. In 2001, the 5-year results showed 76% with good to excellent results. In 2008, at 13 years, 74% of the patients still had good to excellent results. Repeat x-rays and MRI scans were obtained for asymptomatic patients who agreed to participate in this study (Fig. 15-5). In only one MRI was there a persistent bone graft margin, indicating the possibility of delayed incorporation, at 4 years and 7 months postoperatively. The patient was asymptomatic with a congruent articular surface (Fig. 15-6). The significance of this finding is uncertain, but it may not be related to clinical sequelae.

One patient had a 4-cm defect (outside of our recommended defect size), necessitating the transplantation of four graft plugs (Fig. 15-7). In this particular case, the patient was young and wished to undergo osteochondral transplantation as a final effort to temporize the necessity for a knee replacement. The patient was well-informed and accepted a potentially high risk of failure prior to surgery. Ultimately, this patient returned pain-free to playing baseball with his children (see Fig. 15-7C).

Second-look arthroscopy was performed in one case. This patient had a medial femoral osteochondral transplantation graft in August 1997. Two years later, the patient returned with persistent pain and repeat arthroscopy was performed (Fig. 15-8). On second look, the original graft site showed excellent gross congruity, incorporation, and no signs of failure. A new, full-thickness defect was present in the tibia of the opposite compartment. This patient ultimately had a total knee arthroplasty in 1999.

Although difficult to prove, it is possible that osteochondral transplantation may slow the development of arthritis in the absence of mechanical or systemic pathology. Anecdotally, an 85-year -old female patient presented for left total knee arthroplasty. She had received an osteochondral transplant in her right knee 10 years earlier. The comparison x-ray of both knees shown in Figure 15-9 reveals a remarkable difference.

CONCLUSIONS

Osteochondral defects treated by marrow stimulation techniques have resulted in inconsistent long-term results. This has perpetuated the interest in finding alternative methods of treating full-thickness chondral lesions. These include autologous chondrocyte implantation, autologous osteochondral transplantation, fresh osteochondral allografting and bulk allograft, and a number of synthetics, scaffolds and first-, second-, and third-generation cell-based technologies.

The goal of osteochondral transplantation is twofold: (1) to remove the pathology of the osteochondral defect’s cartilage, subchondral bone, and interface; and (2) to replace the defect new graft to decrease the defects surrounding forces. Although there is no nerve fiber or blood supply in the bone plug graft, there is an assumption that the existing joint fluid will allow the cartilage cells to survive. This is further supported by the fact that the plug is harvested and inserted within a short period of time. The bone plug fills in the defect and allows the live hyaline cartilage cells to help fill the graft. If the graft is placed correctly, it will decrease the size of the lesion and direct pressure to the contact surface of the subchondral bone, thus relieving the symptoms. Also, because the bone plug lacks nerve fibers and blood supply, there is no sensitivity at the graft-harvested site.

Full-thickness defects smaller than 1 cm in diameter are not thought to be appropriate for treatment with this technique. They do not seem to be clinically troublesome and do well when left alone. It follows that a smaller defect—only 6 mm in diameter (COR technique donor site)—in an area that is not load bearing and does not affect the patellofemoral articulation should also be well tolerated. These defects fill in without additional bone grafting and are covered with fibrocartilaginous scar, much like the area between donor plugs and the adjacent intact hyaline cartilage.

Overall, experience indicates that the primary goal of osteochondral transplantation is not to reproduce a normal anatomic, physiologic, or biomechanical knee joint surface. The goal of this procedure is simply to decrease the patient’s clinical sequelae regarding the defect being treated. This may be related to decreasing the effective size of the defect, and thus decreasing the biomechanical shear and compressive forces surrounding these defects. This is illustrated by Jason and Koh’s research on force transmissions surrounding peridefect- and periplug-related contact pressures (see Fig. 15-1 and Table 1).5 Because of this phenomenon, this is a forgiving technique and the angle of graft insertion can be 10 to 20 degrees off of perpendicular without clinical consequences. The senior author speculates that the remodeling potential of the narrow fibrocartilage in the inter-graft space may make this possible. This is supported with our second-look arthroscopy findings (Fig. 15-8), and the good to excellent clinical results may be highly related to patient selection.

Arthroscopic osteochondral transplantation is an acceptable option for treating full-thickness osteochondral defects in appropriately selected patients. The arthroscopic technique is straightforward, with a low incidence of complications. The intergraft areas fill in, creating a homogenous appearance. The ability to manage these conditions arthroscopically at the time of discovery offers the advantage of convenience, a single procedure, and cost savings.

REFERENCES

1. McNickle AG, Provencher MT, Cole BJ. Overview of existing cartilage repair technology. Sports Med Arthrosc. 2008;16:196-201.

2. Kerker JT, Leo AJ, Sgaglione NA. Cartilage repair: synthetics and scaffoldsbasic science, surgical techniques, and clinical outcomes. Sports Med Arthrosc. 2008;16:208-216.

3. Sgaglione NA. Biologic approaches to articular cartilage surgery: future trends. Orthop Clin North Am. 2005;36:485-495.

4. Sgaglione N, Miniaci A, Gillogly S, et al. Update on advanced surgical techniques in the treatment of traumatic focal articular cartilage lesions of the knee. Arthroscopy. 2002;18:9-32.

5. Jason L, Koh MD. The effect of graft height mismatch on contact pressures following osteochondral grafting. Am J Sports Med. 2004;32:317-320.

6. Areon A, Loken S, Heir S, et al. Articular cartilage lesions in 993 consecutive knee arthroscopies. Am J Sports Med. 2004;32:211-215.

7. Hjelle K, Solheim E, Strand T. Articular cartilage defects in 1,000 knee arthroscopies. Arthroscopy. 2002;18:730-734.

8. Noyes FR, Bassett RW, Grood ES, et al. Arthroscopy in acute traumatic hemarthrosis of the knee. J Bone Joint Surg Am. 1980;62:687-695.

9. Ferkel RD, Zanotti RM, Komenda GA, et al. Arthroscopic treatment of chronic osteochondral lesions of the talus: long-term results. Am J Sports Med. 2008;36:1750-1762.

10. Sgaglione NA. The future of cartilage restoration. J Knee Surg. 2004;17:235-243.

11. Kon E, Delcogliano M, Filardo G, et al. Second-generation issues in cartilage repair. Sports Med Arthrosc. 2008;16:221-229.

12. Coons DA, Barber FA. Arthroscopic osteochondral autografting. Orthop Clin North Am. 2005;36:447-458.

13. Marcacci M, Kon E, Delcogliano M, et al. Arthroscopic autologous osteochondral grafting for cartilage defects of the knee: prospective study results at a minimum 7-year follow-up. Am J Sports Med. 2007;35:2014-2021.

14. Magnussen RA, Dunn WR, Carey JL, Spindler KP. Treatment of focal articular cartilage defects in the knee: a systematic review. Clin Orthop Relat Res. 2008;(466):952-962.

15. Cain EL, Clancy WG. Treatment algorithm for osteochondral injuries of the knee. Clin Sports Med. 2001;20:321-342.

16. Koulalis D, Di Benedetto P, Citak M, et al. Comparative study of navigated versus freehand osteochondral graft transplantation of the knee. Am J Sports Med. 2009;37:803-807.

17. Hangody L, Vásárhelyi G, Hangody LR, et al. Autologous osteochondral grafting—technique and long-term results. Injury. 2008;39(suppl 1):S32-9.

18. Hangody L, Füles P. Autologous osteochondral mosaicplasty for the treatment of full-thickness defects of weight-bearing joints: ten years of experimental and clinical experience. J Bone Joint Surg Am. 2003;85(suppl 2):25-32.

19. Hangody L, Feczkó P, Bartha L, et al. Mosaicplasty for the treatment of articular defects of the knee and ankle. Clin Orthop Relat Res. 2001;(391 suppl):S328-S336.

20. Kircher J, Patzer T, Magosch P, et al. Osteochondral autologous transplantation for the treatment of full-thickness cartilage defects of the shoulder: results at nine years. J Bone Joint Surg Br. 2009;91:499-503.

21. Patil S, Butcher W, D’Lima DD, et al. Effect of osteochondral graft insertion forces on chondrocyte viability. Am J Sports Med. 2008;36:1726-1732.

22. Barber FA, Chow JCY, Chow JCC. Autogenous osteochondral transplantation. In: Chow JCY, editor. Advanced Arthroscopy. New York: Springer-Verlag; 2000:573-579.

23. Chow JCY, Hantes ME, Houle JB, Zalavras CG. Arthroscopic autogenous osteochondral transplantation for treating knee cartilage defects: a 2 to 5 year follow-up study. Arthroscopy. 2004;20:681-690.

24. Brittberg M, Lindahl A, Nilsson, et al. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med. 1994;331:889-895.

25. Stedman JR, Briggs K, Rodrigo J, et al. Outcomes of microfracture for traumatic chondral defects of the knee: average 11-year follow-up. Arthroscopy. 2003;19:477-484.

26. Alford J, Cole B. Cartilage restoration, part 1: basic science, historical perspective, patient evaluation, and treatment options. Am J Sports Med. 2005;33:295-306.

27. Alford J, Cole B. Cartilage restoration, part 2: techniques, outcomes, and future directions. Am J Sports Med. 2005;33:443-460.

28. Sgaglione N. The biological treatment of focal articular cartilage lesions in the knee: future trends. Arthroscopy. 2003;19:154-160.

29. Brown W, Potter H. Magnetic resonance imaging appearance of cartilage repair in the knee. Clin Orthop Relat Res. 2004;(422):214-223.

30. Sgaglione N. Decision making and approach to articular cartilage surgery. Sports Med Arthrosc Rev. 2003;11:192-201.

31. O’Driscoll S. The healing and regeneration of articular cartilage. J Bone Joint Surg Am. 1998;80:1795-1807.

32. Barber A, Chow J. Arthroscopic osteochondral transplantation: histologic results. Arthroscopy. 2001;17:832-835.

33. Horas U, Pelinkovic D, Aigner T. Autologous chondrocyte implantation and osteochondral cylinder transplantation in cartilage repair of the knee joint: a prospective comparative trial. J Bone Joint Surg Am. 2003;85:185-192.